To this end, our studies used mouse models, cell type–specific deletion of multiple genes, human macrophages from IPAH and SSc-PAH patients, and in vivo nanoparticle-delivered siRNA against Pdgfb. The gene discussed is PDGFB; the disease is idiopathic pulmonary arterial hypertension.